Compare

Shuttle Pharmaceuticals Holdings, Inc. vs Traws Pharma, Inc. vs Longeveron Inc. vs Lantern Pharma Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Shuttle Pharmaceuticals Holdings, Inc. SHPH	Traws Pharma, Inc. TRAWRevenue covers only part of its income (partial revenue)	Longeveron Inc. LGVN	Lantern Pharma Inc. LTRN
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	$1.20M	n/a
Revenue growth (YoY)	n/a	n/a	-49.9%	n/a
Gross margin	n/a	n/a	67.0%	n/a
Operating margin	n/a	n/a	n/m	n/a
Net margin	n/a	n/a	n/m	n/a
Net income	-$11.72M	$9.17M	-$22.70M	-$17.12M
EPS (Diluted)	-$7.16	$0.82	-$1.29	-$1.57
Operating cash flow	-$9.48M	-$18.18M	-$18.64M	-$15.68M
Free cash flow	n/a	-$20.77M	-$18.89M	-$15.68M
Cash & equivalents	$334.0K	n/a	$4.66M	$4.42M
Total assets	$10.48M	$10.62M	$10.26M	$11.04M
Total liabilities	$8.22M	$11.25M	$4.59M	$4.50M
Shareholders' equity	$2.25M	-$629.0K	$5.67M	$6.53M
Return on year-end equity	-519.9%	n/a	-400.1%	-262.0%
Shares outstanding	2.02M	9.07M	n/a	11.25M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Shuttle Pharmaceuticals Holdings, Inc.	Traws Pharma, Inc.	Longeveron Inc.	Lantern Pharma Inc.
Latest	n/a	n/a	$1.20M Ended 2025-12-31	n/a
1 year earlier	n/a	n/a	$2.39M Ended 2024-12-31	n/a
2 years earlier	n/a	n/a	$709.0K Ended 2023-12-31	n/a
3 years earlier	n/a	n/a	$1.22M Ended 2022-12-31	n/a
4 years earlier	n/a	n/a	$1.31M Ended 2021-12-31	n/a